Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Mangalam Drugs and Organics Ltd

MANGALAM.NS ✗ NOT COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$0.34

▲ +7.88%

Market Cap $5.43M · Vol 273.65K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$5.43M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

81.62

Momentum

Beta

0.19

vs Market

52W High

$0.86

63.41% below

52W Low

$0.24

35.71% above

Volume

273.65K

Avg 35.31K

P/B

0.42

Price-to-book

ROE

N/A

Return on equity

Free Float

62.31%

Public shares

Shariah Compliance8 STANDARDS

✗ Mangalam Drugs and Organics Ltd (MANGALAM.NS) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MANGALAM.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+17.33%

+20.65%

+12.70%

+12.47%

YTD

+19.37%

-59.26%

-72.16%

-76.38%

Financials & Valuation

TTM · Annual

Total Revenue	$24.84M
Net Income	$-4,750,859.00
Revenue Growth (YoY)	-0.40%
Gross Margin	24.57%
Operating Margin	-14.27%
Net Profit Margin	-19.13%
ROE	N/A
ROA · ROIC	-14.26% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.19
P/B	0.42
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	15.83M

Technical Indicators

50-Day SMA	$0.29
200-Day SMA	$0.34
RSI (14)	81.62
Beta	0.19
52-Week High	$0.86
52-Week Low	$0.24

Volume Today	273.65K
Avg Daily Volume (30D)	35.31K
Relative Volume	7.75x
Volatility (10D)	58.62
Volatility (30D)	38.69
Free Float	62.31%

Analyst Consensus

N/A

Current Price $0.34

Mean Target N/A

52W Low$0.24 52W High$0.86

Current

Target

$0.24 $0.86

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001SNG8M7

ISININE584F01014

CountryIndia

Sub-IndustryGeneric Pharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

SUNPHARMA.NS Sun Pharmaceutical Industries Ltd +0.63% 4578.T Otsuka Holdings Co Ltd -0.98% CIPLA.NS Cipla Ltd -1.11% ZYDUSLIFE.NS Zydus Lifesciences Ltd +1.88% RICHTER.BU Richter Gedeon Vegyeszeti Gyar Nyrt +0.23%

Company Profile

Mangalam Drugs and Organics Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Under the Company's Fight Malaria Program, it supplies anti-malaria APIs worldwide. Its products include API, intermediates and specialty chemicals. Its API products include acyclovir, amodiaquine, artemether, artesunate, atazanavir sulfate, bisoprolol fumarate, chloroquine phosphate, furosemide and dolutegravir sodium. The Company's intermediates products include 4,6-Dichloro-5-Methoxy Pyrimidine; 4,7- dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base, and tenofovir disoproxil base. Its specialty chemical products include L (+)-menthol; 2,3-dihydrophthalazine-1,4-dione or phthalazine-1,4-dione, and 4-cynoethyl-2-methyl phenol. Its pipeline APIs (under development) include Ganaplacide (IH), Tafenoquine Succinate (IH) and Pretomanid (IH). Its pipeline APIs (developed for research and development) is Bictegravir Na (IH).